We constructed a type 2 diabetes rat model by streptozotocin (STZ) injection and a high-fat diet to investigate the effect and mechanism of exenatide, a GLP-1 receptor agonist, on diabetic cardiomyopathy and cardiomyocyte apoptosis. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.